DSM Venturing was among the investors in a round that will help the lab-grown meat developer widen its product range.
Netherlands-based cultured meat developer Meatable received $47m in series A financing yesterday from investors including DSM Venturing, the corporate venturing arm of health and nutrition product manufacturer Royal DSM.
Section 32, BlueYard Capital, Agronomics, Humboldt and private investors Rick Klausner, Jeffrey Leiden and Taavet Hinrikus also took part in the round.
Meatable is working on laboratory-grown meat that relies on pluripotent cells to replicate the natural process of fat and muscle growth, generating cuts of meat within weeks.
The funding…
